Search results for "proteasome inhibitors" | NDL Search

Search results 6

Group by title

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

Digital博士論文障害者向け資料あり

Nakaue, Emiko, Teramachi, Jumpei, Tenshin, Hirofumi, Hiasa, Masahiro, Harada, Takeshi, Oda, Asuka, Inoue, Yusuke, Shimizu, So, Higa, Yoshiki, Sogabe, Kimiko, Oura, Masahiro, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Yamagami, Hiroki, Endo, Itsuro, Tanaka, Eiji, Abe, MasahiroSpringer Nature2023-04-11

National Diet Library

Note (General)Proteasome inhibitors (PIs) can preferentially rest...

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors 7 48

Digital博士論文障害者向け資料あり

Bat-Erdene, Ariunzaya, Miki, Hirokazu, Oda, Asuko, Nakamura, Shingen, Teramachi, Jumpei, Amachi, Ryota, Tenshin, Hirofumi, Hiasa, Masahiro, Iwasa, Masami, Harada, Takeshi, Fujii, Shiroh, Sogabe, Kimiko, Kagawa, Kumiko, Yoshida, Sumiko, Endo, Itsuro, Aihara, Kenichi, Abe, MasahiroImpact Journals2016-10-12Oncotarget

National Diet Library

Subject Headingmultiple myeloma panobinostat proteasome inhibitors caspase-8 Sp1
Note (General)...synergism with proteasome inhibitors. Although the ......nobinostat and proteasome inhibitors in combination.

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity 180 2

Digital博士論文障害者向け資料あり

Fujii, Shiro, Nakamura, Shingen, Oda, Asuka, Miki, Hirokazu, Tenshin, Hirofumi, Teramachi, Jumpei, Hiasa, Masahiro, Bat-Erdene, Ariunzaya, Maeda, Yusaku, Oura, Masahiro, Takahashi, Mamiko, Iwasa, Masami, Endo, Itsuro, Yoshida, Sumiko, Aihara, Ken-ichi, Kurahashi, Kiyoe, Harada, Takeshi, Kagawa, Kumiko, Nakao, Michiyasu, Sano, Shigeki, Abe, MasahiroWiley2018-01-12British Journal of Haematology

National Diet Library

Note (General)...sistently, the proteasome inhibitors bortezomib and......mbination with proteasome inhibitors is envisioned.

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors

Digital博士論文

バットエルデネ, アリウンザヤ, 三木, 浩和, オダ, アスコ, 中村, 信元, 寺町, 順平, 天知, 良太, 天眞, 寛文, 日浅, 雅博, イワサ, マサミ, 原田, 武志, 藤井, 志朗, 曽我部, 公子, 賀川, 久美子, 吉田, 守美子, 遠藤, 逸朗, 粟飯原, 賢一, 安倍, 正博Impact Journals2016-10-12Oncotarget7 48p.79064-79075

Available onlineOther Libraries in Japan

Summary, etc....synergism with proteasome inhibitors. Although the ......nobinostat and proteasome inhibitors in combination.
Subject Headingmultiple myeloma panobinostat proteasome inhibitors caspase-8 Sp1

Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity

Digital博士論文

藤井, 志朗, 中村, 信元, オダ, アスカ, 三木, 浩和, 天眞, 寛文, 寺町, 順平, 日浅, 雅博, Bat-Erdene, Ariunzaya, マエダ, ユウサク, 大浦, 雅博, タカハシ, マミコ, イワサ, マサミ, 遠藤, 逸朗, 吉田, 守美子, 粟飯原, 賢一, 倉橋, 清衛, 原田, 武志, 賀川, 久美子, 中尾, 允泰, 佐野, 茂樹, 安倍, 正博Wiley2018-01-12British Journal of Haematology180 2p.246-258

Available onlineOther Libraries in Japan

Summary, etc....sistently, the proteasome inhibitors bortezomib and......mbination with proteasome inhibitors is envisioned.

Activating transcription factor 4, an ER stress mediator , is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

Digital博士論文

中村, 信元, 三木, 浩和, キド, シンスケ, ナカノ, アヤコ, 日浅, 雅博, オダ, アスカ, アモウ, ヒロエ, 渡邉, 佳一郎, 原田, 武志, 藤井, 志朗, タケウチ, キョウコ, 賀川, 久美子, オザキ, シュウジ, 松本, 俊夫, 安倍, 正博The Japanese Society of Hematology2013-05-25International Journal of Hematology98 1p.66-73

Available onlineOther Libraries in Japan

Reached to the end of result.

RSS